Diagnosis and Treatment of Multiple Sclerosis: A Review.
McGinley MP, Goldschmidt CH, Rae-Grant AD.
JAMA. 2021 Feb 23;325(8):765-779. doi: 10.1001/jama.2020.26858.
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.
Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19.
Contraception for women with multiple sclerosis: Guidance for healthcare providers.
Houtchens MK, Zapata LB, Curtis KM, Whiteman MK.
Mult Scler. 2017 May;23(6):757-764. doi: 10.1177/1352458517701314. Epub 2017 Mar 24.
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.
Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.
Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.
Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies.
Iyer P, Dobson R.
Neurol Ther. 2023 Feb;12(1):1-10. doi: 10.1007/s40120-022-00421-0. Epub 2022 Nov 28.
The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results.
Thiel S, Ciplea AI, Gold R, Hellwig K.
Ther Adv Neurol Disord. 2021 Nov 22;14:17562864211054956. doi: 10.1177/17562864211054956. eCollection 2021.
[Multiple sclerosis and pregnancy].
Vukusic S, Confavreux C.
Rev Neurol (Paris). 2006 Mar;162(3):299-309. doi: 10.1016/s0035-3787(06)75016-0.
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Voskuhl RR, Wang H, Wu TC, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardens J, Bernard JT, Corboy JR, Cross AH, Dhib-Jalbut S, Ford CC, Frohman EM, Giesser B, Jacobs D, Kasper LH, Lynch S, Parry G, Racke MK, Reder AT, Rose J, Wingerchuk DM, MacKenzie-Graham AJ, Arnold DL, Tseng CH, Elashoff R.
Lancet Neurol. 2016 Jan;15(1):35-46. doi: 10.1016/S1474-4422(15)00322-1. Epub 2015 Nov 29.
Osteopathia Striata with Cranial Sclerosis.
Gear R, Savarirayan R.
2021 Apr 15 [updated 2023 Mar 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Pregnancy and multiple sclerosis: the children of PRIMS.
Vukusic S, Confavreux C.
Clin Neurol Neurosurg. 2006 Mar;108(3):266-70. doi: 10.1016/j.clineuro.2005.11.016. Epub 2006 Jan 4.
